[2] TAHER A T,OTROCK Z K,UTHMAN I,et al.
Thalassemia and hypercoagulability[J]. Blood Rev,
2008,22(5):283-292.
[3] ELDOR A,RACHMILEWITZ E A. The
hypercoagulable state in thalassemia[J]. Blood,2002,
99(1):36-43.
[4] MUKHERJEE A. Moyamoya disease and betathalassemia[
J]. J Assoc Physicians India,1995,43
(10):710-711.
[5] SANEFUJI M,OHGA S,KIRA R,et al. Moyamoya
syndrome in a splenectomized patient with betathalassemia
intermedia[J]. J Child Neurol,2006,21
(1):75-77.
[6] DAS S,DUBEY S,ACHARYA M,et al.
Thalassemia and moyamoya syndrome:unfurling an
intriguing association[J]. J Neurol,2019,266(11):
2838-2847.
[7] CAPPELLINI M D,POGGIALI E,TAHER A T,et
al. Hypercoagulability in β-thalassemia:a status
quo[J]. Expert Rev Hematol,2012,5(5):505-512.
[8] BORENSTAIN-BEN YASHAR V,BARENHOLZ
Y,HY-AM E,et al. Phosphatidylserine in the outer
leaflet of red blood cells from beta-thalassemia
patients may explain the chronic hypercoagulable
state and thrombotic episodes[J]. Am J Hematol,
1993,44(1):63-65.
[9] CRARY S E,BUCHANAN G R. Vascular
complications after splenectomy for hematologic
disorders[J]. Blood,2009,114(14):2861-2868.
[10] 烟雾病和烟雾综合征诊断与治疗中国专家共识编
写组,国家卫生计生委脑卒中防治专家委员会缺血
性卒中外科专业委员会. 烟雾病和烟雾综合征诊断
与治疗中国专家共识(2017)[J]. 中华神经外科杂志,
2017,33(6):541-547.